GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Alpl | increases expression | ISO | ALPL (Homo sapiens) | 6480464 | CTD | Ascorbic Acid results in increased expression of ALPL mRNA | PMID:28105418 | Alpl | multiple interactions | ISO | ALPL (Homo sapiens) | 6480464 | CTD | [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of ALPL mRNA; EZH2 protein inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone] results in increased expression of ALPL mRNA] | PMID:26424790 | Alpl | multiple interactions | ISO | Alpl (Mus musculus) | 6480464 | CTD | [Ascorbic Acid co-treated with Dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of ALPL mRNA; N-(oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide hydrochloride inhibits the reaction [[Ascorbic Acid co-treated with Dexamethasone co-treated with beta-glycerophosphoric acid] results in increased expression of ALPL mRNA] | PMID:26492236 | | ||||||||||||||||||||||
| Go Back to source page | Continue to Ontology report |